AB23468, Abcam, Cambridge, MA)
Zepbound and Mounjaro are both FDA-approved brand-name tirzepatide medications manufactured by Eli Lilly and Company, not compounded preparations
Several peptides used in compounded forms were pulled from compounding lists in late 2023, and many remain available only through research-grade labs
"In combination with diet and exercise, Wegovy is the only obesity medicine proven to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
The SURMOUNT-1 trial tested the ability of tirzepatide to produce weight loss in people with obesity who do not have diabetes
Helping You Protect Your Health and Wealth Well help you find a plan that fits your life, now and in the future